SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy
Top Cited Papers
- 14 March 2001
- journal article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 46 (1-3) , 169-185
- https://doi.org/10.1016/s0169-409x(00)00134-4
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Degradation pathway of kinins in tumor ascites and inhibition by kininase inhibitors: Analysis by HPLCInflammation Research, 1990
- Reduced bone marrow toxicity of neocarzinostatin by conjugation with divinyl ether-maleic acid copolymerEuropean Journal of Cancer and Clinical Oncology, 1990
- Pathogenic potentials of bacterial proteasesClinica Chimica Acta; International Journal of Clinical Chemistry, 1989
- Control of Pharmaceutical Properties of Soybean Trypsin Inhibitor by Conjugation with Dextran I: Synthesis and CharacterizationJournal of Pharmaceutical Sciences, 1989
- Image enhancement in computerized tomography for sensitive diagnosis of liver cancer and semiquantitation of tumor selective drug targeting with oily contrast mediumCancer, 1985
- Selective targeting of anti-cancer drug and simultaneous image enhancement in solid tumors by arterially administered lipid contrast mediumCancer, 1984
- Tailor-making of protein drugs by polymer conjugation for tumor targeting: A brief review on smancsProtein Journal, 1984
- Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary reportEuropean Journal of Cancer and Clinical Oncology, 1983
- Lymphotropic accumulation of an antitumor antibiotic protein, neocarzinostatinPublished by Elsevier ,1980
- Experimental studies on the uptake and retention of labelled proteins in a rat tumourPublished by Elsevier ,1973